Department of Military Affairs Tender by Indian Army (GEM/2025/B/6122213)

Nintedanib 100 mg Soft gelatin cap,Tab Acarbose 25 mg,Tab Telmisartan 20 mg,Carvedilol 6 point 25 m

Goods
Qty:14.1L
EMD: ₹1,450
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6122213)

Tender Timeline

Tender Issue
May 3, 2025 at 12:35 PM

Tender Title: BOQBID

Reference Number: GEM/2025/B/6122213

The Department of Military Affairs, under the Ministry of Defence, is inviting tenders for the procurement of essential pharmaceutical products. This tender, referred to as BOQBID, encompasses a range of specific medications, prominently including Nintedanib 100 mg Soft Gelatin Capsules, Tab Acarbose 25 mg, Tab Telmisartan 20 mg, and Carvedilol 6.25 mg. The total quantity required for this procurement is approximately 1,406,060 units across various products.

Scope of Work and Objectives

The primary objective of this tender is to ensure a sustainable supply of critical medications for military personnel. The selected vendor will be responsible for timely delivery of high-quality pharmaceuticals, complying with all regulatory and industry standards. Key deliverables include:

  • Supply of Nintedanib 100 mg soft gelatin capsules.
  • Supply of Tab Acarbose 25 mg.
  • Supply of Tab Telmisartan 20 mg.
  • Supply of Carvedilol 6.25 mg.
  • Adherence to delivery timelines and logistics requirements.

Eligibility Criteria

Bidders must meet various eligibility requirements to participate in this tender, which includes being a registered pharmaceutical manufacturer or dealer, possessing necessary licenses, and adhering to regulatory norms specified by the Ministry of Defence and relevant health authorities.

Technical Requirements

Participants should ensure that all offered products meet the specified technical requirements set forth in the tender documentation. This includes product specifications, quality compliance standards, and packaging requirements. All products must be certified and comply with pharmaceutical industry quality standards.

Financial Requirements

Bidders are required to submit financial statements indicating their capability to fulfill the tender requirements. All offers should also encompass the total financial value applicable, factoring in taxes, and delivery charges, ensuring clarity and compliance with financial regulations.

Document Submission Details

Prospective bidders must prepare their tender documents in accordance with the prescribed format and submit them via the electronic procurement system. It is essential that all documents are complete to facilitate timely evaluation.

Special Provisions

The tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) to foster inclusivity and competitiveness. Startups will also receive special attention, promoting innovative solutions in pharmaceutical supplies.

Evaluation Process

The evaluation of bids will be conducted in accordance with the outlined criteria, focusing on both technical compliance and financial viability. Bids will be assessed on their ability to meet the required specifications, delivery timeline, and overall cost-effectiveness.

Delivery Locations

Selected bidders will be expected to deliver products to designated military health facilities, as outlined in the tender specifications. Collaboration with logistics providers may be required to ensure a seamless delivery process.

Contact Information

For further details regarding this tender, please refer to the official contact channels provided by the Department of Military Affairs. It is crucial for bidders to stay updated on any amendments or clarifications that may arise during the tender lifecycle.

By participating in this tender, bidders contribute to the wellbeing of military personnel and demonstrate their commitment to delivering quality healthcare products.


Tender BOQ Items

59 Items
1.

Nintedanib 100 mg Soft gelatin cap

Qty:1500
Unit:no
30
2.

Tab Acarbose 25 mg

Qty:104300
Unit:no
30
3.

Tab Telmisartan 20 mg

Qty:39300
Unit:no
30
4.

Carvedilol 6 point 25 mg Tab

Carvedilol 6.25 mg Tab

Qty:29300
Unit:no
30
5.

Tab TRANEXAMIC ACID 250 mg

Qty:12500
Unit:nos
30
6.

Tab Chlorthalidone 12 point 5 mg

Tab Chlorthalidone 12.5 mg

Qty:22300
Unit:no
30
7.

Cilastazole 50 mg Tab

Qty:16200
Unit:no
30
8.

Tab Cilostazole 100 mg

Qty:6100
Unit:no
30
9.

Tab Danazol 100 mg

Qty:4800
Unit:nos
30
10.

Anastrozole 1mg Tab

Qty:12600
Unit:no
30
11.

Cyclosporine A micro emulsion 25 mg Cap

Qty:10400
Unit:no
30
12.

Tab Leflunomide 10 mg

Qty:24000
Unit:no
30
13.

Tab Cinnarizine 25 mg

Tab Cinnarizine 25 mg.

Qty:14100
Unit:no
30
14.

Tab Betahistine 16 mg

Qty:26600
Unit:no
30
15.

Fluvoxamine 50 mg Cap

Qty:13600
Unit:no
30
16.

Isoniazid 300 mg Tab

Qty:3600
Unit:no
30
17.

Gycerl Trinitrate CR 2 point 6 mg, Tab

Gycerl Trinitrate CR 2.6 mg, Tab

Qty:100000
Unit:tab
30
18.

TAB PIRACETAM 800 MG

Qty:6800
Unit:nos
30
19.

Quitiapine 50 mg, Tab

Qty:12900
Unit:no
30
20.

Risperidone 4 mg Tab

Qty:6400
Unit:no
30
21.

Bethanechol 25mg Tab

Qty:1900
Unit:no
30
22.

Tab Tadalafil 10 mg

Qty:9100
Unit:no
30
23.

Mebeverine HCl 135mg Tab

Qty:12200
Unit:no
30
24.

Common Cold Tab Cetrizine 5 mg plus Paracetamol 500 mg plus Pseudoephdrine 60 mg

Common Cold Tab(Cetrizine 5 mg+Paracetamol 500 mg+Pseudoephdrine 60 mg)

Qty:43300
Unit:no
30
25.

Tab Fenofibrate 160 mg

Qty:10700
Unit:no
30
26.

Moxifloxacin Hcl 0 point5 percent plus Dexamethasone 0 point 1 percent ophthalmic soln bott of 5 ml

Moxifloxacin Hcl 0.5 %+ Dexamethasone 0.1 % ophthalmic soln bott of 5 ml

Qty:3900
Unit:bott
30
27.

E slace D Brinzolamide 1 percent

E/D Brinzolamide 1%

Qty:360
Unit:bott
30
28.

Brimonidine 0 point 2 percent plus Timolal eye drops, bott of 5 ml

Brimonidine 0.2 % + Timolal eye drops, bott of 5 ml

Qty:2600
Unit:bott
30
29.

Formeterol 20 mcg plus budesonide 0 point 5 mg respules

Formeterol 20 mcg + budesonide 0.5 mg respules

Qty:3600
Unit:no
30
30.

Human Insulin Analogue Glargine Inj, 100 IU slace ml Recombinant DNA origin 300IU Disposable Pen with 5 needles per pen

Human Insulin Analogue Glargine Inj, 100 IU/ml (Recombinant DNA origin) 300IU Disposable Pen with 5 needles per pen

Qty:10700
Unit:pen
30
31.

Tab Bisoprolol 5mg

Qty:17400
Unit:no
30
32.

Chloridiazepoxide 10 mg Tab

Qty:5700
Unit:no
30
33.

Tab Cilnidipine 5 mg

Qty:46300
Unit:no
30
34.

Glipizide 5 mg Tab

Qty:19100
Unit:no
30
35.

Clobazam 5 mg Tab

Qty:28400
Unit:no
30
36.

Fludrocortisone 0 point 1mg Tab

Fludrocortisone 0.1mg Tab

Qty:600
Unit:no
30
37.

Tab Mirabegron 50 mg

Qty:9900
Unit:no
30
38.

Tab Voglibose 0 point 3 mg

Tab Voglibose 0.3 mg

Qty:16500
Unit:nos
30
39.

Tab Rosuvastatin 10 mg

Qty:95700
Unit:no
30
40.

TAB ZIPRASIDONE 20 MG

Qty:600
Unit:nos
30
41.

Tab Midodrine 2 point 5mg

Tab Midodrine 2.5mg

Qty:1200
Unit:no
30
42.

Tab Dutasteride 0 point 5 mg

Tab Dutasteride 0.5 mg

Qty:188300
Unit:no
30
43.

Tab Clotrimazole 100 mg Vaginal Pessary

Qty:1200
Unit:no
30
44.

Tab Donepezil 10mg

Qty:16800
Unit:no
30
45.

Tab Methotrexate 15 mg

Qty:3500
Unit:no
30
46.

Tab Melatonin 3 mg

Qty:1500
Unit:no
30
47.

Fluconazole 0 point3 percent wslace v bott of 5 ml

Fluconazole 0.3% w/v bott of 5 ml

Qty:60
Unit:bott
30
48.

Rizatriptan 5 mg Tab

Qty:1300
Unit:no
30
49.

Timolol Maleate 0 point 5 percent Preservative Free with Comod System

Timolol Maleate 0.5% Preservative Free with Comod System

Qty:740
Unit:vial
30
50.

Tab Primidone 250 MG

Qty:3900
Unit:no
30
51.

Chloramphenicol 5 percent w slace v Clotrimazole 1 percent w slace v Betamethasone 0 point 25 percent wslace v Lignocaine HCL 2percent w slace v in bott of 5 ml

Chloramphenicol 5% w/v Clotrimazole 1% w/v Betamethasone 0.25 % w/v Lignocaine HCL 2% w/v in bott of 5 ml

Qty:2500
Unit:bott
30
52.

Cough Lozenges

Qty:4900
Unit:no
30
53.

Fluoxetine HCl 20 mg Cap

Qty:30500
Unit:no
30
54.

Tamsulosin 0 point 4mg and Dutasteride 0 point 5mg combination Cap slaceTab

Tamsulosin 0.4mg and Dutasteride 0.5mg combination Cap/Tab

Qty:48000
Unit:no
30
55.

Amlodipine 10 mg Tab

Qty:158300
Unit:no
30
56.

Alprazolam 0 point 5 Mg Tab

Alprazolam 0.5 Mg Tab

Qty:34500
Unit:nos
30
57.

Dimethyl Fumarate 240 mg delayed release Capsules containing microteblets

Qty:2100
Unit:nos
30
58.

Isosorbide Mononitrate 20 mg Tab

Qty:59800
Unit:no
30
59.

Tab Levetiracetam 250mg

Qty:41100
Unit:no
30

General Information

Item Category
Nintedanib 100 mg Soft gelatin cap , Tab Acarbose 25 mg , Tab Telmisartan 20 mg , Carvedilol 6 point 25 mg Tab , Tab TRANEXAMIC ACID 250 mg , Tab Chlorthalidone 12 point 5 mg , Cilastazole 50 mg Tab , Tab Cilostazole 100 mg , Tab Danazol 100 mg , Anastrozole 1mg Tab , Cyclosporine A micro emulsion 25 mg Cap , Tab Leflunomide 10 mg , Tab Cinnarizine 25 mg , Tab Betahistine 16 mg , Fluvoxamine 50 mg Cap , Isoniazid 300 mg Tab , Gycerl Trinitrate CR 2 point 6 mg, Tab , TAB PIRACETAM 800 MG , Quitiapine 50 mg, Tab , Risperidone 4 mg Tab , Bethanechol 25mg Tab , Tab Tadalafil 10 mg , Mebeverine HCl 135mg Tab , Common Cold Tab Cetrizine 5 mg plus Paracetamol 500 mg plus Pseudoephdrine 60 mg , Tab Fenofibrate 160 mg , Moxifloxacin Hcl 0 point5 percent plus Dexamethasone 0 point 1 percent ophthalmic soln bott of 5 ml , E slace D Brinzolamide 1 percent , Brimonidine 0 point 2 percent plus Timolal eye drops, bott of 5 ml , Formeterol 20 mcg plus budesonide 0 point 5 mg respules , Human Insulin Analogue Glargine Inj, 100 IU slace ml Recombinant DNA origin 300IU Disposable Pen with 5 needles per pen , Tab Bisoprolol 5mg , Chloridiazepoxide 10 mg Tab , Tab Cilnidipine 5 mg , Glipizide 5 mg Tab , Clobazam 5 mg Tab , Fludrocortisone 0 point 1mg Tab , Tab Mirabegron 50 mg , Tab Voglibose 0 point 3 mg , Tab Rosuvastatin 10 mg , TAB ZIPRASIDONE 20 MG , Tab Midodrine 2 point 5mg , Tab Dutasteride 0 point 5 mg , Tab Clotrimazole 100 mg Vaginal Pessary , Tab Donepezil 10mg , Tab Methotrexate 15 mg , Tab Melatonin 3 mg , Fluconazole 0 point3 percent wslace v bott of 5 ml , Rizatriptan 5 mg Tab , Timolol Maleate 0 point 5 percent Preservative Free with Comod System , Tab Primidone 250 MG , Chloramphenicol 5 percent w slace v Clotrimazole 1 percent w slace v Betamethasone 0 point 25 percent wslace v Lignocaine HCL 2percent w slace v in bott of 5 ml , Cough Lozenges , Fluoxetine HCl 20 mg Cap , Tamsulosin 0 point 4mg and Dutasteride 0 point 5mg combination Cap slaceTab , Amlodipine 10 mg Tab , Alprazolam 0 point 5 Mg Tab , Dimethyl Fumarate 240 mg delayed release Capsules containing microteblets , Isosorbide Mononitrate 20 mg Tab , Tab Levetiracetam 250mg
Ministry Name
Organisation Name

Financial Information

EMD Amount
₹1,450.00
Bid Offer Validity
180 (Days)
Past Performance
20 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

5 Documents
GeM-Bidding-7720053.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Frequently Asked Questions

The eligibility requirements for this tender include the need for bidders to be a registered pharmaceutical manufacturer or dealer with the necessary licenses. Compliance with the Ministry of Defence regulations is mandatory, alongside previous experience in successfully delivering pharmaceutical products to governmental or large-scale entities.

Bidders must include various necessary certificates during the submission, which include but are not limited to: a valid manufacturing license, GST registration, and quality compliance certificates such as ISO or WHO-GMP certification. These documents validate the quality and compliance of the offered medications.

The registration process involves submitting an online application through the designated procurement portal. Bidders must ensure that they have a valid account, which includes uploading all required legal documents and financial statements to verify their eligibility.

All submitted documents must be in PDF format to ensure compatibility and ease of review. Additionally, bidders should ensure that all scanned documents are clear and legible to facilitate an effective evaluation process.

The payment terms stipulated for this tender typically imply a contract agreement wherein payment will be made upon successful delivery and acceptance of the products. Moreover, provisions for an Earnest Money Deposit (EMD) and performance security may be required to ensure compliance with the contract terms and conditions.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders